Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2150100 | 0.89 | RAPGEF4 (0.46) | MAPTSMN1; SMN2MAPK1ALDH1A1LMNA | |
| SCHEMBL606274 | 0.88 | MAPT (0.40) | MAPTSMN1; SMN2MAPK1ALDH1A1LMNA | |
| SCHEMBL30477867 | 0.78 | MAPT (0.52) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 | |
| SCHEMBL13580077 | 0.78 | MAPT (0.52) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 | |
| SCHEMBL10019438 | 0.78 | MAPT (0.52) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 | |
| SCHEMBL12388896 | 0.78 | MAPT (0.52) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 | |
| SCHEMBL23875735 | 0.78 | MAPT (0.44) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 | |
| SCHEMBL3718540 | 0.75 | HPGD (0.59) | MAPTSMN1; SMN2MAPK1ALDH1A1LMNA | |
| SCHEMBL1655412 | 0.74 | CNR2 (0.46) | — | |
| SCHEMBL23868592 | 0.74 | TP53 (0.42) | MAPTSMN1; SMN2ALDH1A1LMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9577199-B2 | Deuterated compounds for electronic applications | E I DU PONT NEMOURS AND COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-9260657-B2 | Chrysene compounds for luminescent applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-02-16 | — | — | US | disclosed |
| EP-2671936-B1 | Chrysene compounds for luminescent applications | DU PONT (US) | 2015-06-24 | — | — | EP | disclosed |
| EP-2432849-B1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | DU PONT (US) | 2015-02-25 | — | — | EP | disclosed |
| US-20150021586-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | LG CHEM, LTD. (KR) | 2015-01-22 | — | — | US | disclosed |
| US-8890131-B2 | Deuterated compounds for electronic applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| US-8759818-B2 | Deuterated compounds for electronic applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-06-24 | — | — | US | disclosed |
| EP-2674469-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-18 | — | — | EP | disclosed |
| EP-2671936-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-11 | — | — | EP | disclosed |
| EP-2669351-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-04 | — | — | EP | disclosed |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | US | disclosed |
| US-20110215715-A1 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-09-08 | — | — | US | disclosed |
| EP-2350230-A2 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E. I. du Pont de Nemours and Company (US) | 2011-08-03 | — | — | EP | disclosed |
| WO-2011087815-A2 | DEUTERATED ZIRCONIUM COMPOUND FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-21 | — | — | WO | disclosed |
| US-20110148287-A1 | DEUTERATED ZIRCONIUM COMPOUND FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-23 | — | — | US | disclosed |
| WO-2011071507-A1 | DEUTERATED COMPOUND AS PART OF A COMBINATION OF COMPOUNDS FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-16 | — | — | WO | disclosed |
| US-20110133632-A1 | DEUTERATED COMPOUND AS PART OF A COMBINATION OF COMPOUNDS FOR ELECTRONIC APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-06-09 | — | — | US | disclosed |
| WO-2011028216-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20110037057-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-17 | — | — | US | disclosed |
| WO-2010059837-A2 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215715-A1 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | CRY2, CRY1, CYBA | MAPT 1206/4885SMN1; SMN2 4587/4885MAPK1 2113/4885 |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | CRY2, CENPE, CRY1 | MAPT 1308/4885SMN1; SMN2 4138/4885MAPK1 2874/4885 |
| US-20110148287-A1 | DEUTERATED ZIRCONIUM COMPOUND FOR ELECTRONIC APPLICATIONS | SLC39A3, SLC39A11, EED | MAPT 2542/4885SMN1; SMN2 3669/4885MAPK1 3391/4885 |
| US-20110037057-A1 | DEUTERATED COMPOUNDS FOR ELECTRONIC APPLICATIONS | DDT, AHR, EED | MAPT 3496/4885SMN1; SMN2 3130/4885MAPK1 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.